American Trust Investment Advisors’s AbbVie ABBV Stock Holding History

American Trust Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,438	Closed	-$393K	–	60
2019 Q4	$393K	Hold	4,438	–	–	0.29%	48
2019 Q3	$336K	Sell	4,438 -190	-4%	-$13K	0.26%	49
2019 Q2	$337K	Sell	4,628 -217	-4%	-$17.1K	0.26%	47
2019 Q1	$390K	Sell	4,845 -225	-4%	-$18.4K	0.3%	49
2018 Q4	$467K	Buy	5,070 +70	+1%	+$6.16K	0.41%	45
2018 Q3	$473K	Buy	5,000 +150	+3%	+$14.2K	0.37%	47
2018 Q2	$449K	Buy	4,850 +385	+9%	+$37.6K	0.37%	50
2018 Q1	$423K	Hold	4,465	–	–	0.34%	50
2017 Q4	$432K	Sell	4,465 -145	-3%	-$13.7K	0.34%	52
2017 Q3	$410K	Sell	4,610 -255	-5%	-$19.4K	0.37%	47
2017 Q2	$353K	Buy	4,865 +100	+2%	+$6.72K	0.31%	53
2017 Q1	$310K	Buy	4,765 +1,145	+32%	+$72K	0.28%	51
2016 Q4	$227K	Sell	3,620 -565	-14%	-$34.5K	0.22%	61
2016 Q3	$264K	Sell	4,185 -110	-3%	-$7.12K	0.27%	53
2016 Q2	$266K	Buy	4,295 +590	+16%	+$36K	0.27%	55
2016 Q1	$212K	Buy	+3,705	New	+$207K	0.22%	58

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

American Trust Investment Advisors's ABBV Position: Q1 2020 in Review

American Trust Investment Advisors sold out of AbbVie (ABBV) in Q1 2020, closing a stake of 4,438 shares — an estimated $393K sold.

American Trust Investment Advisors first reported a position in ABBV in Q1 2016 and held it in 16 quarters. The position peaked at $473K in Q3 2018. 2,225 funds tracked by Wall St. Rank hold ABBV as of Q1 2020.

American Trust Investment Advisors reported no remaining AbbVie position as of Q1 2020 after selling out during the quarter.
American Trust Investment Advisors sold 4,438 AbbVie shares in Q1 2020, an estimated $393K.
American Trust Investment Advisors first reported a position in AbbVie in Q1 2016 and held it in 16 quarters.
American Trust Investment Advisors's AbbVie position peaked at $473K in Q3 2018.
2,225 funds tracked by Wall St. Rank held AbbVie as of Q1 2020.

Based on American Trust Investment Advisors's 13F filing for Q1 2020, filed 15 May 2020.